Buy or sell 4D Molecular Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Request Access
View More Companies

4D Molecular Therapeutics Stock

4D Molecular Therapeutics’ mission is to design and develop transformative gene therapy products using our proprietary.

About 4D Molecular Therapeutics Stock

4D Molecular Therapeutics, we are unlocking the full potential of the gene therapy field. Our customized AAV vectors can deliver genes to any cell in the body to eradicate disease.

Funding History

August 2015$7.0M
September 2017$3.0M

Management

Co-Founder

David Schaffer

COO

Anthony Davies

Co-Founder, President & CEO

David Kirn

Press

Other Companies

23andMe Logo
Learn More
Learn More
23andMe
Human Genome Research
14Age (years)
$877MTotal Funding
Bayer Logo
Learn More
Learn More
Bayer
Multinational pharmaceutical and life sciences company
157Age (years)
$3.0BTotal Funding
Twist Bioscience Logo
Learn More
Learn More
Twist Bioscience
Synthetic DNA production for specialty chemical compounds and drug development Twist Bioscience Corp.
8Age (years)
$253MTotal Funding
Veritas Genetics Logo
Learn More
Learn More
Veritas Genetics
Genetic testing platform
7Age (years)
$547MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from 4D Molecular Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 200K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo